Completed PHASE4 NCT00986076

Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery

Randomized Clinical Trial Evaluating Anti-inflammatory Effect of Low Molecular-Weight Heparin in Pediatric Cataract and Intraocular Lens Surgery

Sponsor: Iladevi Cataract and IOL Research Center

Conditions Inflammation

Interventions Balanced Salt Solution Enoxaparin

Updated 5 times since 2017 Last updated: Sep 28, 2009 Started: Mar 31, 2008 Primary completion: Apr 30, 2009 Completion: Sep 30, 2009

This PHASE4 trial investigates Inflammation and is currently completed. Iladevi Cataract and IOL Research Center leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iladevi Cataract and IOL Research Center

Data source: Iladevi Cataract and IOL Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ahmedabad, India